Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIO-RAD LABORATORIES, INC.BIO BIO.B · Entity 2247 | EVP, GBL Commercial Operations | September 04, 2026 | September 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIO-RAD LABORATORIES, INC.
Report date September 04, 2026 · Filed September 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 599.052 |
Reported balance
After 2026-09-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-05 · Exercise / conversion · Acquired 456 · Balance 599.052 F1: Shares of Class A common stock acquired on the vesting of restricted stock units. F2: Includes 57.9370, 53.0810 and 32.0340 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/2025, 03/31/2026 and 06/30/2026, respectively. |
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 366.052 |
Reported balance
After 2026-09-05 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-09-05 · Tax withholding · Disposed 233 · Balance 366.052 |
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 1,736.052 |
Reported balance
After 2026-09-05 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-09-05 · Exercise / conversion · Acquired 1,370 · Balance 1,736.052 F1: Shares of Class A common stock acquired on the vesting of restricted stock units. |
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 1,232.052 |
Reported balance
After 2026-09-05 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-09-05 · Tax withholding · Disposed 504 · Balance 1,232.052 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 4,601 |
Reported balance
After 2026-09-04 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-04 · Grant · Acquired 4,601 · Balance 4,601 F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,371 |
Reported balance
After 2026-09-05 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-05 · Exercise / conversion · Disposed 456 · Balance 1,371 F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 4,110 |
Reported balance
After 2026-09-05 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-05 · Exercise / conversion · Disposed 1,370 · Balance 4,110 F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Includes 57.9370, 53.0810 and 32.0340 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/2025, 03/31/2026 and 06/30/2026, respectively.
F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter.
F5: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 05, 2026 Filed Sep 9, 2026 22:44 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 1,370 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002081681-26-000002 · wk-form4_1788993866.xml · derivative · entry 7 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,110 Underlying: Bio-Rad A Common Stock · 1,370 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F5 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:44 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 456 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002081681-26-000002 · wk-form4_1788993866.xml · derivative · entry 6 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,371 Underlying: Bio-Rad A Common Stock · 456 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F5 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:44 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 504 | $386.11 | $194,599.44 |
DisclosureSEC source: 0002081681-26-000002 · wk-form4_1788993866.xml · nonDerivative · entry 4 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,232.052 Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:44 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 1,370 | $0.00 | $0.00 |
DisclosureSEC source: 0002081681-26-000002 · wk-form4_1788993866.xml · nonDerivative · entry 3 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,736.052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:44 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 233 | $386.11 | $89,963.63 |
DisclosureSEC source: 0002081681-26-000002 · wk-form4_1788993866.xml · nonDerivative · entry 2 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 366.052 Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:44 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 456 | $0.00 | $0.00 |
DisclosureSEC source: 0002081681-26-000002 · wk-form4_1788993866.xml · nonDerivative · entry 1 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 599.052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 57.9370, 53.0810 and 32.0340 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/2025, 03/31/2026 and 06/30/2026, respectively. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 22:44 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | GrantRestricted Stock Units · Derivative | 4,601 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002081681-26-000002 · wk-form4_1788993866.xml · derivative · entry 5 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,601 Underlying: Bio-Rad A Common Stock · 4,601 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. F4 · derivative.expiration_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:19 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | GrantRestricted Stock Units · Derivative | 5,480 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002081681-25-000008 · wk-form4_1757449148.xml · derivative · entry 2 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,480 Underlying: Bio-Rad A Common Stock · 5,480 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F3 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:19 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | GrantRestricted Stock Units · Derivative | 1,827 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002081681-25-000008 · wk-form4_1757449148.xml · derivative · entry 1 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,827 Underlying: Bio-Rad A Common Stock · 1,827 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: On September 5, 2025, the reporting person was granted 1,827 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On September 5, 2025, the reporting person was granted 1,827 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.